Zomedica Corp. balance sheet ZOMDF

Annual Quarterly

As of Sep 30, 2026, Zomedica Corp. had total assets of $115.0 million and total liabilities of $10.7 million. Total assets were down 12.1% from a year earlier. Stockholders' equity was $104.3 million. It held $7.3 million in cash and investments against $1.6 million of total debt, net cash of $5.6 million. The current ratio, current assets divided by current liabilities, was 6.09.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2022 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017
Assets
Cash	7 -2.9%	9 +28.4%	7 -45.8%	13 -93.4%	27	195	62 +12041.3%	1 -73.7%	2 -43.7%	3
Cash and investments	7 -2.9%	9 +28.4%	7 -45.8%	13 -93.4%	27	195	62 +12041.3%	1 -73.7%	2 -43.7%	3
Receivables	7 +116.0%	3 +24.3%	2 +102.4%	1 +100.8%	1	—	0 +116.2%	0 +26.0%	0 +89.8%	0
Inventory	6 +4.5%	6 +9.6%	5 -1.3%	5 +79.9%	3	3	—	—	—	—
Total current assets	55 -14.3%	64 -21.7%	82 -18.1%	100 -50.2%	124	200	64 +3434.8%	2 -53.2%	4 -9.4%	4
Property and equipment, net	20 -8.5%	21 -15.0%	25 +7.7%	23 +1920.2%	7	1	1 -20.0%	1 +1.7%	1 +93.2%	0
Goodwill	0	0 -100.0%	46 -26.0%	62 +42.3%	64	43	—	—	—	—
Total assets	115 -12.1%	127 -38.7%	207 -18.1%	253 -9.7%	280	280	66 +1481.3%	4 -30.7%	6 +15.7%	5
Liabilities and equity
Accounts payable	2 +27.5%	2 -10.9%	2	—	—	—	—	—	—	—
Total current liabilities	9 +7.9%	9 +1.3%	9 +3.3%	9 +108.1%	8	4	2 -2.8%	2 -12.2%	2 +186.8%	1
Total liabilities	11 -4.2%	12 -0.5%	12 -11.3%	13 +38.6%	12	10	3	—	—	—
Stockholders' equity	104 -12.9%	115 -41.0%	196 -18.5%	240 -11.4%	267	271	51 +2337.2%	2 -42.7%	4 -16.6%	4
Debt
Debt due within a year	—	—	—	—	—	0	—	—	—	—
Long-term debt	—	—	—	—	—	—	1	—	—	—
Lease liabilities	2 -30.0%	2 +20.4%	2 -33.6%	3 +98.0%	2	1	1	—	—	—
Total debt	2 -30.0%	2 +20.4%	2 -33.6%	3 +98.0%	2	1	2	—	—	—
Net cash	6 +9.5%	7 +31.2%	5 -49.1%	10 -94.7%	26	194	60	—	—	—
Ratios
Current ratio	6.09x	6.78x	8.76x	11.06x	15.81x	46.18x	31.48x	0.87x	1.62x	5.14x
Debt to equity	0.02x	0.02x	0.01x	0.01x	0.01x	0.01x	0.04x	—	—	—
Return on equity	-15.34%	-70.94%	-24.01%	-14.39%	-6.36%	-6.28%	-33.11%	-944.14%	-455.23%	-183.84%
Return on assets	-13.91%	-64.44%	-22.66%	-13.64%	-6.09%	-6.07%	-25.57%	-472.97%	-275.92%	-154.63%
Book value per share	0.11	0.12	0.20	0.24	0.27	0.28	0.08	0.02	0.04	0.05

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: ZOMDF (OTC)
Fiscal year ends: December 31
Incorporated in: Alberta, Canada
Headquarters: Ann Arbor, MI
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1684144
Former names: Zomedica Pharmaceuticals Corp. (until Sep 28, 2020)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.